1 High-Flying Stock for Long-Term Investors and 2 We Question
3 Reasons to Avoid SGRY and 1 Stock to Buy Instead
Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations
3 of Wall Street’s Favorite Stocks We Find Risky
3 Stocks Under $50 We Keep Off Our Radar
SURGERY PARTNERS (SGRY) GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve...
3 Small-Cap Stocks with Warning Signs
Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations